February 10, 2017 – Philadelphia, PA The Hybridtide platform technology is highlighted in an Angewandte Chemie publication: New Modalities for Challenging Targets in Drug Discovery.
Read More
February 7, 2017 – Philadelphia, PA Longevity Biotech and University of Nebraska Medical center announce follow-on funding for the development of LBT-3627 as a novel therapeutic strategy for Parkinson’s disease.
Read More
UPDATED: FEB 7, 2017 Furthers development of LBT-3627 focusing on immunomodulatory therapeutic strategy to treat Parkinson's disease Philadelphia, PA, February 7, 2017 (Newswire.com) -Longevity Biotech, Inc. (LBT) and the University of Nebraska…
Read More
October 20, 2016 – San Francisco, CA Longevity Biotech is attending the Breakout Labs Unboxing event.
Read More
June 21, 2016 – Omaha, NE & Philadelphia, PA UNMC & Longevity Biotech publish novel neurodegenerative diagnostic imaging approach for Parkinson’s disease using LBT-3627.
Read More
June 6-7, 2016 – Atlanta, GA Longevity Biotech will attend the NSF Phase II SBIR Conference.
Read More
June 6-9, 2016 – San Francisco, CA Longevity Biotech will participate as part of the Innovation zone Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist…
Read More
March 14-15, 2016 – Cambridge, MA Longevity Biotech Presents at Boulder Peptide Symposium East
Read More
April 6-7, 2016 – Boston, MA Longevity Biotech Presents at NIO Neurotech Investing and Partnering conference
Read More
March 8th, 2016 – Cambridge, MA Longevity Biotech Presents at Breakout Labs Portfolio Day
Read More